| INSPIREMD 1/18 DL-,0001 |
| USA |
| Gesundheit |
| US45779A8466 / A3CMP3 |
| II2 (Frankfurt) / NSPR (NASDAQ) |
| FRA:II2, ETR:II2, II2:GR, NASDAQ:NSPR |
| - |
| https://www.inspiremd.com.. |
|
InspireMD, Inc. is a medical device company that develops and commercializes products for the treatment of carotid artery disease and other vascular conditions. The company’s portfolio centers on its proprietary CGuard™ carotid stent platform and..
>Volltext.. |
| 25.37 Mio. EUR |
| 9.89 Mio. EUR |
| 9.6 Mio. EUR |
| - |
| -45.05 Mio. EUR |
| -0.54 EUR |
| 1.56 Mio. EUR |
| 17.5 Mio. EUR |
| - |
| 2.25 |
| 40.62% |
| -11.07% |
| - |
| - |
| - |
| INSPIREMD |
| 18.11.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|